Insulin Pump Market Analysis

Insulin Pump Market Analysis

To get key market trends

  Download Free Sample

The market by product is categorized into devices and accessories. The devices segment accounted for dominating share and was valued at USD 4.5 billion revenue in 2023. The devices segment is further bifurcated into tubed/tethered, and tubeless segments.
 

• Tubed pumps offer continuous insulin delivery, which is essential for maintaining basal insulin levels throughout the day. This continuous infusion closely mimics the physiological insulin release in a healthy pancreas.
   
• Tubeless insulin pumps are designed to be user-friendly, with simple insertion processes and minimal steps for activation. This ease of use is attractive to individuals who may be new to pump therapy or prefer a straightforward approach.
   
• Further, the demand for tubeless pumps is consistently increasing as these pumps may reduce the risk of occlusions, as there is no tubing that can be blocked or kinked. This is anticipated to contribute to improved reliability in insulin delivery for patients.
   

The insulin pump market by end-use is categorized into home care, hospitals & clinics, and other end-users. The home care segment accounted for around USD 3 billion revenue size in 2023.
 

• Homecare settings empower patients to take an active role in their diabetes management. Insulin pumps, with their user-friendly interfaces and educational support, promote patient engagement and self-efficacy in insulin therapy.
   
• Technological advancements, such as the development of smaller, more discreet pumps with improved user interfaces, contribute to the adoption of insulin pumps in homecare.
   
• Insulin pumps reduce the need for multiple daily injections, providing a more comfortable and less invasive option for insulin delivery. This reduction in the injection burden is especially beneficial for individuals who manage their diabetes at home.
   

North America insulin pump market accounted for USD 2.3 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• Reimbursement policies and coverage for insulin pumps by healthcare insurers in North America can significantly impact market growth. Improved reimbursement options make insulin pump therapy more accessible and affordable for patients.
   
• Additionally, recommendations from healthcare professionals, including endocrinologists and diabetes educators, play a crucial role in driving the adoption of insulin pumps. Positive feedback and endorsements from healthcare providers contribute to increased patient acceptance.
   
• The need for effective and convenient insulin delivery systems is growing as more individuals are diagnosed with diabetes in the region. For instance, according to The National Diabetes Statistics Report, 2022 over 37 million people (around 11.3% of the total population) has diabetes in the U.S. in 2019. This data is expected to rise substantially, thereby, propelling the industry expansion.